BDBM458160 US10752615, Compound 52

SMILES C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(N(C)C(=O)C4CC4)ccc31)C2

InChI Key InChIKey=RXBBNYOZZYEKJZ-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 458160   

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandChemical structure of BindingDB Monomer ID 458160BDBM458160(US10752615, Compound 52)
Affinity DataIC50: 0.390nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Gb005

US Patent
LigandChemical structure of BindingDB Monomer ID 458160BDBM458160(US10752615, Compound 52)
Affinity DataIC50: 0.580nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Gb005

US Patent
LigandChemical structure of BindingDB Monomer ID 458160BDBM458160(US10752615, Compound 52)
Affinity DataIC50: 0.790nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase Tec(Human)
Gb005

US Patent
LigandChemical structure of BindingDB Monomer ID 458160BDBM458160(US10752615, Compound 52)
Affinity DataIC50: 1.13nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent